Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer
	    		
		   		
		   			
		   		
	    	
    	- Author:
	        		
		        		
		        		
			        		Isabel ÑIGUEZ SEVILLA
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Francisco MACHADO LINDE
			        		
			        		;
		        		
		        		
		        		
			        		Maria del Pilar MARÍN SÁNCHEZ
			        		
			        		;
		        		
		        		
		        		
			        		Julián Jesús ARENSE
			        		
			        		;
		        		
		        		
		        		
			        		Amparo TORROBA
			        		
			        		;
		        		
		        		
		        		
			        		Anibal NIETO DÍAZ
			        		
			        		;
		        		
		        		
		        		
			        		Maria Luisa SÁNCHEZ FERRER
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Original Article
 - Keywords: Endometriosis; Ovarian Cancer; Hyperplasia
 - MeSH: Diagnosis; Endometriosis; Female; Humans; Hyperplasia; Ovarian Neoplasms; Prevalence; Prospective Studies
 - From:Journal of Gynecologic Oncology 2019;30(4):e63-
 - CountryRepublic of Korea
 - Language:English
 - Abstract: OBJECTIVE: Patients with endometriosis are at increased risk of ovarian cancer. It has been suggested that atypical endometriosis is a precursor lesion of endometriosis-associated ovarian cancer (EAOC). The aim of this study is to evaluate if cytologic (cellular) atypia and architectural atypia (hyperplasia), histologic findings described as atypical endometriosis, play a different role in patients with EAOC. METHODS: A prospective study was conducted between January 2014 and April 2017 at our institution with patients undergoing surgery with a histologic diagnosis of endometriosis, ovarian cancer, or EAOC. The prevalence and immunohistologic study (Ki-67, BAF250a, COX-2) of cases of cellular and architectural atypia in endometriosis were analyzed. RESULTS: Two hundred and sixty-six patients were included: the diagnosis was endometriosis alone in 159 cases, ovarian cancer in 81, and EAOC in 26. Atypical endometriosis was reported in 23 cases (12.43%), 39.13% of them found in patients with EAOC. Endometriosis with cellular atypia was found mainly in patients without neoplasm (71.4%), and endometriosis with architectural atypia was seen in patients with ovarian cancer (88.9%) (p=0.009). Ki-67 was significantly higher in endometriosis patients with architectural atypia than those with cellular atypia. CONCLUSION: The diagnosis of endometriosis with architectural atypia is important because it may be a precursor lesion of ovarian cancer; therefore, pathologists finding endometriosis should carefully examine the surgical specimen to identify any patients with hyperplasia-type endometriosis, as they may be at higher risk of developing EAOC.
 
            